Clinical Trial Update: A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia [Phase 1]

View source ↗

Summary

Update on a Phase I trial of 4SCAR19 cells for relapsed/refractory B-cell acute lymphoblastic leukemia. The trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• 4SCAR19 Cells

Snippet

Sponsor: The First People's Hospital of Yunnan | Conditions: B Acute Lymphoblastic Leukemia | Phase 1 | Status: UNKNOWN